Rambam Health Corporation
Date of Award
Crohn's Disease, Israel
Term of Grant
Predicting and optimizing drug therapy in Crohn's disease: A path to novel therapeutic agents
Treatment efficacy during Crohn’s disease is incomplete with only a small fraction of patient maintaining long term response to therapies. This study aims to personalize therapies to increase effectiveness and efficiency of treatments, and provide patients with durable remission and improved quality of life.